Breaking Down Crescent Capital BDC, Inc. Financial Health: Key Insights for Investors

Crescent Capital BDC (CCAP) is trading at $14.65 (last trade Dec 19, 17:15 PST) with a market cap of $541.94 million and a steep 11.95% dividend yield that crowns a story of steady revenue growth-total revenue rose to $197.36 million for the year ended Dec 31, 2024-even as NAV slid to $19.62 at March 31, 2025 and net investment income per share softened (Q1 2025: $0.45 vs Q4 2024: $0.55); the portfolio has expanded to $1.62 billion across 191 companies, concentrated in Software & Services (28%) and Healthcare Equipment & Services (17%), while leverage sits at $894 million of debt against total assets of $1.67 billion (debt-to-equity 1.25x) and liquidity includes $30.5 million cash plus $310 million undrawn capacity-factors that interact with a falling weighted average yield on income-producing securities (10.4% in Q2 2025 from 12.2% a year earlier), a tight dividend coverage ratio (Q2 2025 NII per share $0.46 vs combined dividends $0.47), non-accruals of 3.5% at cost (1.8% at fair value), a recent P/E of 15.08 and forward P/E of 8.98, and analyst optimism (Buy, $16.50 PT); read on to unpack what these concrete metrics mean for income-seeking and risk-aware investors.

Crescent Capital BDC, Inc. (CCAP) - Revenue Analysis

• Core revenue source: interest income from floating‑rate and fixed‑rate private debt instruments to middle‑market companies.
• Supplemental revenue: origination and monitoring fees, prepayment penalties, and occasional realized/unrealized gains on portfolio exits.
• Revenue sensitivity: interest rate movements (impact on portfolio yield vs. funding costs) and credit performance of the underlying loan portfolio.

• Interest rate environment - impact on new deal yields and cost of leverage.
• Portfolio credit quality - non‑accruals, impaired loans, and recovery rates influence net interest income and realized losses.
• Leverage usage and funding mix - spreads between portfolio yield and borrowing costs determine net investment income.
• Portfolio turnover and exits - realization events can produce meaningful one‑time gains or losses that affect total revenue.

Crescent Capital BDC, Inc. (CCAP) - Profitability Metrics

• Total revenue (FY 2024): $197.36 million (+7.18% vs FY 2023 $184.13M)
• Total investment income (Q4 2024 → Q1 2025): $46.4M → $42.1M
• Interest & dividend income (Q4 2024 → Q1 2025): $45.8M → $41.3M
• Weighted average yield on income-producing securities (Q2 2025): 10.4% (down from 12.2% YoY)
• Portfolio market value (Q1 2025): $1.62 billion across 191 companies (up from 185 companies)
• Top sector concentrations: Software & Services 28%; Healthcare Equipment & Services 17%

• Revenue growth in FY 2024 was healthy (+7.18%) but Q1 2025 investment income softness and falling yields suggest margin pressure.
• Declining quarter interest/dividend income and a lower weighted average yield indicate either yield compression on new investments or mix-shift toward lower-yielding assets.
• Portfolio expansion to $1.62B and an increased company count (191) demonstrate deployment activity and diversification across issuers, with notable concentration in Software & Services and Healthcare Equipment & Services.

Crescent Capital BDC, Inc. (CCAP) - Debt vs. Equity Structure

• Profitability snapshot (reported): net investment income (NII) per share for year ended 12/31/2024: $2.40; net income per share for year ended 12/31/2024: $1.99.
• Quarterly trend: Q1 2025 NII per share: $0.45 (down from $0.55 in Q4 2024); Q1 2025 net income per share: $0.11 (down from $0.27 in Q4 2024).
• NAV movement: $19.98 at 12/31/2024 → $19.62 at 3/31/2025 (decline of $0.36, ~1.8%).
• Dividends: regular cash dividend declared for Q2 2025 = $0.42 per share; combined regular + special dividends in Q2 2025 = $0.47 per share.
• Dividend coverage (Q2 2025): NII per share $0.46 covering combined dividends $0.47 - coverage is tight (coverage ratio ≈ 0.98x).

• With NII trending down from Q4 2024 to Q1 2025, pressure on cash-flow coverage increases if dividends remain at ~current levels.
• NAV modestly declined (-$0.36 per share), which can reflect mark-to-market impacts on loan portfolio values or realized losses; persistent NAV declines would erode equity cushions against leverage.
• Tight dividend coverage (NII $0.46 vs. payouts $0.47) suggests limited buffer to support distributions if credit costs or prepayment / fee income weaken.
• Debt financing (senior secured loans, credit lines, or repurchase facilities typical for BDCs) magnifies the impact of portfolio mark-to-market swings on equity; any increase in cost of debt or covenant pressure would constrain flexibility.
• Management's decision to keep the regular dividend at $0.42 for Q2 2025 signals a priority on distribution stability despite narrower coverage-monitor for changes in mix of regular vs. special dividends.

• Quarterly NII trend and components (interest income minus interest expense, fees, realized gains/losses).
• Portfolio credit performance metrics - non-accruals, delinquencies, and upgrades/downgrades affecting valuations.
• Leverage levels and borrowing costs; any shifts in facility terms or covenant thresholds.
• Composition of dividends (regular vs. special) and management commentary on sustainability.

Crescent Capital BDC, Inc. (CCAP) - Liquidity and Solvency

• Total assets: $1.67 billion (as of 3/31/2025)
• Total debt obligations: $894 million (as of 3/31/2025)
• Cash & cash equivalents: $30.5 million (as of 3/31/2025)
• Undrawn debt capacity: $310.0 million (as of 3/31/2025)

• Debt-to-equity ratio: 1.25x in Q1 2025 (up from 1.19x in prior quarter)
• Asset coverage: 179% in Q1 2025 (down from 189% in prior quarter)
• Weighted average stated interest rate on debt outstanding: ~6.3% in Q1 2025
• Weighted average yield on income-producing securities: 10.4% in Q2 2025

• Immediate liquidity: $30.5M cash provides a near-term cushion for operations and short-term obligations.
• Committed borrowing capacity: $310.0M undrawn capacity supports opportunistic lending and liquidity flexibility.
• Spread between yield and funding cost: with a 10.4% portfolio yield versus ~6.3% cost of debt, CCAP retains gross spread to cover operating expenses, credit losses and distributions, but narrowing spreads or rising funding costs would pressure net interest margin.

Crescent Capital BDC, Inc. (CCAP) - Valuation Analysis

• Declared regular cash dividend: $0.42 per share for Q2 2025 (consistent policy).
• Net investment income (NII) per share: $0.46 in Q2 2025, covering combined regular and special dividends of $0.47 - indicating tight dividend coverage.
• Weighted average stated interest rate on debt outstanding: ~6.3% in Q1 2025.
• Weighted average yield on income-producing securities: 10.4% in Q2 2025.
• Cash and cash equivalents: $30.5 million as of March 31, 2025.
• Undrawn debt capacity: $310.0 million as of March 31, 2025.
• Debt maturity profile: no significant maturities until 2026, reducing near-term refinancing risk.

• Yield on assets (10.4%) vs. cost of debt (6.3%) implies a gross interest spread of ~4.1 percentage points before fees, leverage cost and credit losses.
• Tight dividend coverage and modest cash balances increase reliance on available undrawn capacity and portfolio cash flow.

• Leverage benefit: The spread between portfolio yield and debt cost supports net interest margin, but narrower coverage increases sensitivity to credit losses or yield compression.
• Liquidity buffer: $30.5M cash plus $310M undrawn capacity provides runway to cover distributions and manage portfolio needs, but actual utilization would raise interest expense and leverage.
• Refinancing timeline: Absence of large maturities until 2026 reduces immediate rollover risk; however, market rate moves could affect future funding costs.
• Dividend sustainability: With NII per share ($0.46) slightly below combined payouts ($0.47), sustaining distributions may require either improved portfolio income, capital gains, or temporary use of liquidity/borrowings.

• Portfolio yield changes vs. funding cost movements (spread compression/expansion).
• Credit performance and realized losses that would reduce NII and NAV.
• Utilization of undrawn capacity and impact on interest expense.
• Any changes to dividend policy or issuance of special dividends affecting coverage dynamics.

Crescent Capital BDC, Inc. (CCAP) - Risk Factors

• Yield vs. Price: The 11.95% dividend yield makes CCAP attractive for income-focused investors but also reflects underlying credit and liquidity risk priced into the equity.
• P/E and Forward P/E Divergence: Trailing P/E of 15.08 versus forward P/E of 8.98 implies expected earnings acceleration or one-time adjustments-confirm through upcoming earnings and portfolio performance.
• Market Cap and Liquidity: With ~$542M market cap and a relatively low beta (0.58), CCAP tends to be less volatile than the broader market but may still experience thin trading and wider spreads relative to larger REITs/BDCs.
• Analyst Target vs. Range: A $16.50 target offers ~12.6% upside from the 12/19/2025 close but sits well below the 52-week high, signaling mixed sentiment about upside durability.

• Credit Risk: As a BDC heavily invested in leveraged and middle-market loans, portfolio credit quality deterioration would pressure NAV, earnings, and dividend coverage.
• Interest Rate Sensitivity: Funding costs and net interest margin compression from rising short-term rates can reduce distributable income; conversely, rates falling could improve margin but lower yield attractiveness.
• Dividend Sustainability: High current yield (11.95%) may not be sustainable if non-accruals rise or realized losses increase-verify coverage metrics (core earnings, pre-tax income, net investment income).
• Valuation Re-rating: Forward P/E of 8.98 implies market expectations for earnings growth; failure to meet projections could trigger a re-rating toward the lower end of the 52-week range.
• Liquidity & Market Risk: Smaller market cap and episodic volume can exacerbate price moves during stress, despite beta indicating lower systematic volatility historically.
• Leverage and Covenant Risk: Portfolio-level leverage and borrower covenant exposure can accelerate losses in downturns; review leverage ratios and facility terms in filings.
• Macro & Sector Concentration: Adverse trends in sectors where CCAP is concentrated may cause correlated defaults and impaired recoveries.

• Track monthly/quarterly portfolio performance: non-accruals, weighted-average yields, realized losses.
• Watch interest expense trends and facility maturities to assess funding pressure.
• Verify dividend coverage from core NII and adjusted earnings rather than relying solely on cash yield.
• Compare NAV per share trends against market price and the 52-week trading band ($13.03-$20.19).
• Monitor analyst updates relative to the $16.50 target and changes in consensus ratings.

Crescent Capital BDC, Inc. (CCAP) - Growth Opportunities

Risk Factors

• Weighted average yield on income-producing securities declined to 10.4% in Q2 2025 from 12.2% a year earlier, pressuring portfolio-level cash yield.
• Non-accruals represented 3.5% of the portfolio at cost and 1.8% at fair value as of March 31, 2025, indicating stressed credits concentrated in a modest portion of the book.
• Debt-to-equity ratio increased to 1.25x in Q1 2025 from 1.19x in the prior quarter, raising leverage and interest coverage sensitivity.
• Asset coverage decreased to 179% from 189% in the prior quarter, narrowing cushion against creditor claims and valuation shocks.
• The weighted average stated interest rate on debt outstanding was approximately 6.3% in Q1 2025, creating a higher fixed financing cost environment relative to portfolio yields.
• Liquidity remains a mitigant: $30.5 million in cash and cash equivalents and $310.0 million of undrawn debt capacity as of March 31, 2025.

Implications for Investors

• Lower portfolio yields vs. a year ago compress net investment income; monitoring spread between portfolio yield (10.4%) and funding cost (~6.3%) is critical.
• Rising leverage (1.25x) and declining asset coverage (179%) increase sensitivity to further markdowns or credit deterioration.
• Non-accruals at cost (3.5%) signal pockets of credit stress; fair value non-accruals (1.8%) suggest partial valuation recognition already taken.
• Solid liquidity ($30.5M cash + $310.0M undrawn capacity) provides runway for new originations, working capital, and opportunistic purchases despite headwinds.